普利製藥(300630.SZ):董事親屬買賣公司可轉債構成短線交易
格隆匯5月21日丨普利製藥(300630.SZ)公佈,公司董事周茂的母親徐淑如於2021年3月8日賣出公司可轉換公司債券“普利轉債”(“可轉債”),該交易構成短線交易行為。經核查,徐淑如買賣公司可轉債的情況如下:

根據《關於可轉換公司債券適用短線交易相關規定的通知》的規定,可轉債屬於《證券法》規定的其他具有股權性質的證券,無論是否進入轉股期,均適用短線交易的相關規定。周茂於2021年2月9日通過原股東優先配售方式買入公司可轉債20892張(截止目前周茂該持有數量未發生變化,周茂未發生任何違規行為),徐淑如將其所持公司可轉債在6個月內賣出的行為構成短線交易。
徐淑如此次短線交易行為產生的收益為1225.31元,收益金額的計算方法為:賣出價格×賣出債券數-買入價格×買入債券數-手續費=118.3×67-100×67-0.79=1225.31元。徐淑如已將獲利金額全數上交公司。
公司在獲知上述短線交易行為後,公司高度重視,及時核查相關情況。經核實,周茂事先未知曉其母親徐淑如交易公司可轉債的相關情況。徐淑如系不瞭解可轉債相關法律、法規的規定而誤操作,不存在主觀違規情況。並且相關短線交易不存在因獲悉內幕信息而謀求利益的情形,亦不存在利用短線交易謀求利益的目的。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.